Colonial River Investments’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AIM
SLAM
CWP
Colonial River Investments's PFE Position: Q2 2026 in Review
Colonial River Investments reduced its Pfizer (PFE) stake by 11% in Q2 2026, selling an estimated $68.5K and leaving 21,713 shares worth $523K. The position accounts for 0.15% of the portfolio, ranked #122.
Colonial River Investments first reported a position in PFE in Q4 2020 and has held it in 22 quarters since. The position peaked at $1.5M in Q4 2022. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Colonial River Investments held 21,713 shares of Pfizer worth $523K as of Q2 2026.
- Colonial River Investments sold 2,619 Pfizer shares in Q2 2026, an estimated $68.5K.
- Pfizer made up 0.15% of Colonial River Investments's portfolio in Q2 2026, its #122 holding.
- Colonial River Investments first reported a position in Pfizer in Q4 2020 and has held it in 22 quarters since.
- Colonial River Investments's Pfizer position peaked at $1.5M in Q4 2022.
- 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Colonial River Investments's 13F filing for Q2 2026, filed 24 Jul 2026.